SlideShare a Scribd company logo
1 of 3
Download to read offline
Dear Colleague,
Women infected with HIV are at increased risk for the development of cervical cancer
precursors, which are associated with infection by human papillomavirus (HPV). As
many as 60% of HIV-infected women are co-infected with some type of HPV, while
24% may be infected by three or more types. Approximately 20% of co-infected women
develop HPV-induced pre-malignant lesions of the uterine cervix within three years of
an HIV diagnosis. Left untreated, HPV-associated lesions may lead to invasive cervical
cancer, an AIDS-defining illness.
While recent advances in highly active antiretroviral therapy(HAART) have contributed
to a decline in AIDS incidence, the therapeutic effect of HAART on HPV clearance and
the incidence of cervical dysplasia is not entirely known. Other therapeutic options
include a novel preventative HPV vaccine that also might prove to be of some benefit
to both HIV-infected and at-risk women.
Please join us as we investigate the role of HPV infection among women living with or
at risk for HIV infection.
THE PLANNING COMMITTEE
Dennis Thomas
Coordinator, BRUNAP
Susan Cu-Uvin, MD
Assoc Professor Ob-Gyn & Medicine
Brown Medical School
David Pugatch, MD
Assistant Professor of Pediatrics
Brown Medical School
Herb Harwell, MD
Asst Professor Medicine and Pediatrics
Brown Medical School
Carol Browning, MS, RN, C
Community Health Nurse Coordinator
RI Department of Health
Janice Miller, M Ed
Director, Brown Office of CME
Brown Medical School
HIV/HPVAMONGWOMEN
Wednesday,June 21,2006 • 5:30 - 9:00 p.m.
— A dinner program presented by Brown University AIDS Program —
Providence Marriott Hotel
Accreditation The program will offer 3 AMA PRA Category 1 Credits™; CEU accreditation for nurses (3.6 hrs) is pending.
Target Audience Primary care physicians, physician assistants, nurse practitioners, and nurses who provide primary health
care services to women who are HIV-infected or who have CDC-defined AIDS.
SPONSORED BY THE BROWN UNIVERSITY AIDS PROGRAM • LIFESPAN/TUFTS/BROWN CENTER
FOR AIDS RESEARCH • BROWN MEDICAL SCHOOL OFFICE OF CONTINUING MEDICAL EDUCATION
COURSE OBJECTIVES
At the conclusion of this
course, participants should
be able to:
1) Discuss the epidemiol-
ogy and pathogenesis of hpv
and hpv-associated diseases
among hiv-infected women;
2) identify appropriate treat-
ment/interventions for cer-
vical dysplasia among hiv-in-
fected women;
3) discuss the influence of
haart on cervical dysplasia
and hpv infection;
4) describe vaccine strate-
gies for the prevention and
therapy of hpv infection and
cervical dysplasia and/or
cancer.
Directions & Parking
The Providence Marriott Hotel is located at One Orms St. Parking is free.
From Rt 95 North: take Exit 23 (Capitol Offices Exit). Stay right at the fork, then make a left at the light onto Orms
Street. The hotel will be on the left.
From Rt 95 South: take Exit 23 (Charles Street Exit). At end of ramp turn right, then take first left onto Ashburton
Street. The hotel will be on the right.
Agenda
5:30-6:00 pm REGISTRATION AND BUFFET DINNER
6:00-6:10 WELCOME AND INTRODUCTION
6:10-6:40 HIV AND HPV
E. Milu Kojic, MD • Assistant Professor, Medicine, Brown Medical School and The Miriam
Hospital
6:40-7:10 TREATMENT OF CERVICAL DISEASE
Lori Boardman, MD • Associate Professor, Obstetrics and Gynecology, Brown Medical School;
Director, Vulvar and Colonoscopy Clinics, Women and Infants Hospital Women’s Primary
Care Center
7:10-8:10 UPDATE ON THE HPV VACCINE TRIAL
Michael Steller, MD • Clinical Professor, Obstetrics and Gynecology, Tufts University School of
Medicine; Division Chief, Gynecologic Oncology, St. Elizabeth’s Medical Center
8:10-8:40 HPV VACCINE TRIAL IMPLEMENTATION
Michelle Lally, MD • Assistant Professor, Medicine, Brown Medical School
8:40-9:00 Q&A; CLOSING REMARKS
Accreditation
Brown Medical School is accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.
Brown Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1
Credits™. Physicians should claim only credit commensurate with the extent of their participation in the
activity.
Continuing Education Units are accredited through the New EnglandAIDS Education and Training Center
and the Board of Registration in Nursing of the Commonwealth of Massachusetts. Pending confirmation,
this session has been approved for 3.6 contact hours.
HIV/HPVAMONGWOMEN
THIS PROGRAM IS SUPPORTED BY
THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER UNDER GRANT 2 H4A HA 00050-04-0
BOEHRINGER-INGELHEIM
THE LIFESPAN/TUFTS/BROWN CENTER FOR AIDS RESEARCH
MERCK & CO.
Box G-C Providence, RI 02912
t 401 383 3005 ❥ f 401 383 3006 ❥ brunap@brown.edu
www.brown.edu/brunap/
brunapBrown University AIDS Program
EDUCATIONAL GRANTS FOR THIS PROGRAM PROVIDED BY:
HIV/HPV Among Women • Wednesday,June 21,2006
Name _________________________________________________________ Degree* ___________________
Address __________________________________________________________________________________
City/State/Zip _____________________________________________________________________________
Telephone ________________________________________________________________________________
Medical Specialty___________________________________________________________________________
*Nurses—please also provide license number.
Registration Form
Brown University AIDS Program and Brown Medical School
HIV/HPV AMONG WOMEN
Wednesday,June 21,2006 • 5:30-9:00 p.m.
The dinner and program are free. Registrations are not accepted by telephone.
For questions or information,please telephone the BRUNAP office at 401.383.3005.
To ensure proper CME/CEU credit,be assured of seating,and help us plan accurately for the number attending,
PLEASE FILL OUT THE REGISTRATION INFORMATION BELOW AND RETURN IT TO US BY JUNE 16,2006.
Please PRINT CLEARLY or type the requested information.
Mail to:
BROWN UNIVERSITY AIDS PROGRAM
BOX G-C
PROVIDENCE,RI 02912
Or fax to:
401.383.3006

More Related Content

What's hot

Cancer Screening in a Middle Income Country: Malaysia's experience
Cancer Screening in a Middle Income Country: Malaysia's experienceCancer Screening in a Middle Income Country: Malaysia's experience
Cancer Screening in a Middle Income Country: Malaysia's experienceArunah Chandran
 
Nutrition Surveillance and Counselling for Cancer Survivors
Nutrition Surveillance and Counselling for Cancer Survivors Nutrition Surveillance and Counselling for Cancer Survivors
Nutrition Surveillance and Counselling for Cancer Survivors Canadian Cancer Survivor Network
 
Genetic Testing for Cancer Risk
Genetic Testing for Cancer RiskGenetic Testing for Cancer Risk
Genetic Testing for Cancer Riskflasco_org
 
1. what is hepatitis c virus final
1. what is hepatitis c virus final1. what is hepatitis c virus final
1. what is hepatitis c virus finalantoine piaton
 
8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid finalantoine piaton
 
CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...Canadian Cancer Survivor Network
 
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...Graham Colditz
 
3. hcv screening diagnosis and disease assessment final
3. hcv screening diagnosis and disease assessment final3. hcv screening diagnosis and disease assessment final
3. hcv screening diagnosis and disease assessment finalantoine piaton
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSNikole Gettings
 
Thalassemia demographics statistics
Thalassemia demographics statisticsThalassemia demographics statistics
Thalassemia demographics statisticssohaibmazam
 
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAsCCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAsCanadian Cancer Survivor Network
 
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020Canadian Cancer Survivor Network
 
World’s First Saliva Test Detects Hidden Throat Cancer
World’s First Saliva Test Detects Hidden Throat CancerWorld’s First Saliva Test Detects Hidden Throat Cancer
World’s First Saliva Test Detects Hidden Throat CancerAPRN World
 
9. tackling the hepatitis c epidemic global landscape final
9. tackling the hepatitis c epidemic global landscape final9. tackling the hepatitis c epidemic global landscape final
9. tackling the hepatitis c epidemic global landscape finalantoine piaton
 

What's hot (20)

Cancer Screening in a Middle Income Country: Malaysia's experience
Cancer Screening in a Middle Income Country: Malaysia's experienceCancer Screening in a Middle Income Country: Malaysia's experience
Cancer Screening in a Middle Income Country: Malaysia's experience
 
International Journal of Hepatology & Gastroenterology
International Journal of Hepatology & GastroenterologyInternational Journal of Hepatology & Gastroenterology
International Journal of Hepatology & Gastroenterology
 
Nutrition Surveillance and Counselling for Cancer Survivors
Nutrition Surveillance and Counselling for Cancer Survivors Nutrition Surveillance and Counselling for Cancer Survivors
Nutrition Surveillance and Counselling for Cancer Survivors
 
Genetic Testing for Cancer Risk
Genetic Testing for Cancer RiskGenetic Testing for Cancer Risk
Genetic Testing for Cancer Risk
 
1. what is hepatitis c virus final
1. what is hepatitis c virus final1. what is hepatitis c virus final
1. what is hepatitis c virus final
 
8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final
 
CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...
 
WEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast DensityWEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast Density
 
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
 
HPV Prevention for Cancer Survivors
HPV Prevention for Cancer SurvivorsHPV Prevention for Cancer Survivors
HPV Prevention for Cancer Survivors
 
Breast ca risk
Breast ca riskBreast ca risk
Breast ca risk
 
3. hcv screening diagnosis and disease assessment final
3. hcv screening diagnosis and disease assessment final3. hcv screening diagnosis and disease assessment final
3. hcv screening diagnosis and disease assessment final
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
 
Thalassemia demographics statistics
Thalassemia demographics statisticsThalassemia demographics statistics
Thalassemia demographics statistics
 
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAsCCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
 
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
 
Global Health Catalyst Cancer Summit at Harvard V7
Global Health Catalyst Cancer Summit at Harvard V7Global Health Catalyst Cancer Summit at Harvard V7
Global Health Catalyst Cancer Summit at Harvard V7
 
safe opinoid
safe opinoidsafe opinoid
safe opinoid
 
World’s First Saliva Test Detects Hidden Throat Cancer
World’s First Saliva Test Detects Hidden Throat CancerWorld’s First Saliva Test Detects Hidden Throat Cancer
World’s First Saliva Test Detects Hidden Throat Cancer
 
9. tackling the hepatitis c epidemic global landscape final
9. tackling the hepatitis c epidemic global landscape final9. tackling the hepatitis c epidemic global landscape final
9. tackling the hepatitis c epidemic global landscape final
 

Similar to Women&HIV_flyer_06_web_version

Demystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdfDemystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdfLija Mary Mathew
 
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...IIJSRJournal
 
Human deficiency immune virus infection -HIV
Human deficiency immune virus infection -HIVHuman deficiency immune virus infection -HIV
Human deficiency immune virus infection -HIVThangamjayarani
 
A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013Hivlife Info
 
A New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of AntiretroviralsA New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of Antiretroviralshivlifeinfo
 
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdfBIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdfbkbk37
 
Cervical cancer-screening-day 2
Cervical cancer-screening-day 2Cervical cancer-screening-day 2
Cervical cancer-screening-day 2kusumkumari27
 
Cervical-Cancer-Screening (1).ppt
Cervical-Cancer-Screening (1).pptCervical-Cancer-Screening (1).ppt
Cervical-Cancer-Screening (1).pptAhmadjavidZarang
 
Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...
Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...
Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...Humphrey Misiri
 
HIV IN PREGNANCY.pptx
HIV IN PREGNANCY.pptxHIV IN PREGNANCY.pptx
HIV IN PREGNANCY.pptxOluwatomisin1
 
Technologies for cervical cancer lecture
Technologies for cervical cancer lectureTechnologies for cervical cancer lecture
Technologies for cervical cancer lectureRida Fatima
 
45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...
45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...
45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...Vivek Ghosh
 
HIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfrica
HIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfricaHIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfrica
HIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfricaSavannah Stewart
 
Annals_ACTM Dec 2007 pgs43-49 @ 6 Dec
Annals_ACTM Dec 2007 pgs43-49 @ 6 DecAnnals_ACTM Dec 2007 pgs43-49 @ 6 Dec
Annals_ACTM Dec 2007 pgs43-49 @ 6 DecKaye McArthur
 

Similar to Women&HIV_flyer_06_web_version (20)

Demystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdfDemystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdf
 
Cervical cancer bronchure
Cervical cancer bronchureCervical cancer bronchure
Cervical cancer bronchure
 
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...
 
CANSA HPV and CERVICAL CANCER 2023
CANSA HPV and CERVICAL CANCER 2023CANSA HPV and CERVICAL CANCER 2023
CANSA HPV and CERVICAL CANCER 2023
 
Research paper
Research  paperResearch  paper
Research paper
 
Vacunacion pvh
Vacunacion pvhVacunacion pvh
Vacunacion pvh
 
Human deficiency immune virus infection -HIV
Human deficiency immune virus infection -HIVHuman deficiency immune virus infection -HIV
Human deficiency immune virus infection -HIV
 
A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013
 
A New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of AntiretroviralsA New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of Antiretrovirals
 
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdfBIOS242 Human Papilloma Virus Epidemiology Paper.pdf
BIOS242 Human Papilloma Virus Epidemiology Paper.pdf
 
Cervical cancer-screening-day 2
Cervical cancer-screening-day 2Cervical cancer-screening-day 2
Cervical cancer-screening-day 2
 
Hiv basic concept
Hiv basic conceptHiv basic concept
Hiv basic concept
 
Cervical-Cancer-Screening (1).ppt
Cervical-Cancer-Screening (1).pptCervical-Cancer-Screening (1).ppt
Cervical-Cancer-Screening (1).ppt
 
Gnurpptfinal
GnurpptfinalGnurpptfinal
Gnurpptfinal
 
Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...
Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...
Are Public Antenatal Clinics in Blantyre, Malawi, Ready to Offer Services for...
 
HIV IN PREGNANCY.pptx
HIV IN PREGNANCY.pptxHIV IN PREGNANCY.pptx
HIV IN PREGNANCY.pptx
 
Technologies for cervical cancer lecture
Technologies for cervical cancer lectureTechnologies for cervical cancer lecture
Technologies for cervical cancer lecture
 
45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...
45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...
45_Technologies_for_cervical_cancer_detection_diagnosis_monitoring_and_treatm...
 
HIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfrica
HIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfricaHIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfrica
HIVHPVandtheRiskofInvasiveCervicalCancerinWomeninSub-SaharanAfrica
 
Annals_ACTM Dec 2007 pgs43-49 @ 6 Dec
Annals_ACTM Dec 2007 pgs43-49 @ 6 DecAnnals_ACTM Dec 2007 pgs43-49 @ 6 Dec
Annals_ACTM Dec 2007 pgs43-49 @ 6 Dec
 

Women&HIV_flyer_06_web_version

  • 1. Dear Colleague, Women infected with HIV are at increased risk for the development of cervical cancer precursors, which are associated with infection by human papillomavirus (HPV). As many as 60% of HIV-infected women are co-infected with some type of HPV, while 24% may be infected by three or more types. Approximately 20% of co-infected women develop HPV-induced pre-malignant lesions of the uterine cervix within three years of an HIV diagnosis. Left untreated, HPV-associated lesions may lead to invasive cervical cancer, an AIDS-defining illness. While recent advances in highly active antiretroviral therapy(HAART) have contributed to a decline in AIDS incidence, the therapeutic effect of HAART on HPV clearance and the incidence of cervical dysplasia is not entirely known. Other therapeutic options include a novel preventative HPV vaccine that also might prove to be of some benefit to both HIV-infected and at-risk women. Please join us as we investigate the role of HPV infection among women living with or at risk for HIV infection. THE PLANNING COMMITTEE Dennis Thomas Coordinator, BRUNAP Susan Cu-Uvin, MD Assoc Professor Ob-Gyn & Medicine Brown Medical School David Pugatch, MD Assistant Professor of Pediatrics Brown Medical School Herb Harwell, MD Asst Professor Medicine and Pediatrics Brown Medical School Carol Browning, MS, RN, C Community Health Nurse Coordinator RI Department of Health Janice Miller, M Ed Director, Brown Office of CME Brown Medical School HIV/HPVAMONGWOMEN Wednesday,June 21,2006 • 5:30 - 9:00 p.m. — A dinner program presented by Brown University AIDS Program — Providence Marriott Hotel Accreditation The program will offer 3 AMA PRA Category 1 Credits™; CEU accreditation for nurses (3.6 hrs) is pending. Target Audience Primary care physicians, physician assistants, nurse practitioners, and nurses who provide primary health care services to women who are HIV-infected or who have CDC-defined AIDS. SPONSORED BY THE BROWN UNIVERSITY AIDS PROGRAM • LIFESPAN/TUFTS/BROWN CENTER FOR AIDS RESEARCH • BROWN MEDICAL SCHOOL OFFICE OF CONTINUING MEDICAL EDUCATION COURSE OBJECTIVES At the conclusion of this course, participants should be able to: 1) Discuss the epidemiol- ogy and pathogenesis of hpv and hpv-associated diseases among hiv-infected women; 2) identify appropriate treat- ment/interventions for cer- vical dysplasia among hiv-in- fected women; 3) discuss the influence of haart on cervical dysplasia and hpv infection; 4) describe vaccine strate- gies for the prevention and therapy of hpv infection and cervical dysplasia and/or cancer.
  • 2. Directions & Parking The Providence Marriott Hotel is located at One Orms St. Parking is free. From Rt 95 North: take Exit 23 (Capitol Offices Exit). Stay right at the fork, then make a left at the light onto Orms Street. The hotel will be on the left. From Rt 95 South: take Exit 23 (Charles Street Exit). At end of ramp turn right, then take first left onto Ashburton Street. The hotel will be on the right. Agenda 5:30-6:00 pm REGISTRATION AND BUFFET DINNER 6:00-6:10 WELCOME AND INTRODUCTION 6:10-6:40 HIV AND HPV E. Milu Kojic, MD • Assistant Professor, Medicine, Brown Medical School and The Miriam Hospital 6:40-7:10 TREATMENT OF CERVICAL DISEASE Lori Boardman, MD • Associate Professor, Obstetrics and Gynecology, Brown Medical School; Director, Vulvar and Colonoscopy Clinics, Women and Infants Hospital Women’s Primary Care Center 7:10-8:10 UPDATE ON THE HPV VACCINE TRIAL Michael Steller, MD • Clinical Professor, Obstetrics and Gynecology, Tufts University School of Medicine; Division Chief, Gynecologic Oncology, St. Elizabeth’s Medical Center 8:10-8:40 HPV VACCINE TRIAL IMPLEMENTATION Michelle Lally, MD • Assistant Professor, Medicine, Brown Medical School 8:40-9:00 Q&A; CLOSING REMARKS Accreditation Brown Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Brown Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Continuing Education Units are accredited through the New EnglandAIDS Education and Training Center and the Board of Registration in Nursing of the Commonwealth of Massachusetts. Pending confirmation, this session has been approved for 3.6 contact hours. HIV/HPVAMONGWOMEN THIS PROGRAM IS SUPPORTED BY THE NEW ENGLAND AIDS EDUCATION AND TRAINING CENTER UNDER GRANT 2 H4A HA 00050-04-0 BOEHRINGER-INGELHEIM THE LIFESPAN/TUFTS/BROWN CENTER FOR AIDS RESEARCH MERCK & CO. Box G-C Providence, RI 02912 t 401 383 3005 ❥ f 401 383 3006 ❥ brunap@brown.edu www.brown.edu/brunap/ brunapBrown University AIDS Program EDUCATIONAL GRANTS FOR THIS PROGRAM PROVIDED BY:
  • 3. HIV/HPV Among Women • Wednesday,June 21,2006 Name _________________________________________________________ Degree* ___________________ Address __________________________________________________________________________________ City/State/Zip _____________________________________________________________________________ Telephone ________________________________________________________________________________ Medical Specialty___________________________________________________________________________ *Nurses—please also provide license number. Registration Form Brown University AIDS Program and Brown Medical School HIV/HPV AMONG WOMEN Wednesday,June 21,2006 • 5:30-9:00 p.m. The dinner and program are free. Registrations are not accepted by telephone. For questions or information,please telephone the BRUNAP office at 401.383.3005. To ensure proper CME/CEU credit,be assured of seating,and help us plan accurately for the number attending, PLEASE FILL OUT THE REGISTRATION INFORMATION BELOW AND RETURN IT TO US BY JUNE 16,2006. Please PRINT CLEARLY or type the requested information. Mail to: BROWN UNIVERSITY AIDS PROGRAM BOX G-C PROVIDENCE,RI 02912 Or fax to: 401.383.3006